drugset / Trial / NCT05655351

Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives.

NCT05655351 ↗

Phase 0 Completed 30 enrolled Nîmes University Hospital
NaSingle-groupOpen-labelPrevention

Summary

Knowing that the vaccine antigen includes the ACE2 binding moiety (RBD), the hypothesis is that circulating vaccine antigen could reduce the enzymatic activity of ACE2, and thus increase circulating AngII concentration, monocyte ROS production and lymphocyte apoptosis. This hypothesis is supported by the fact that the Spike protein of SARSCoV-1, which uses the same receptor as SARS-CoV-2, induces a decrease in expression and activation of the Angiotensin II pathway in mice (Kuba et al. 2005).

Timeline

Start
2022-12-21
Primary completion
2024-07-30
Completion
2024-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject anti-SARS-Cov-2 vaccination Messenger RNA (mRNA) — —